Clinical Trial Update: Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluated memantine for Fragile X-Associated Tremor/Ataxia Syndrome. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Premutation Carriers
• Fragile X-associated Tremor Ataxia Syndrome

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of California, Davis | Conditions: Fragile X-Associated Tremor/Ataxia Syndrome, Fragile X Premutation Carriers | NA | Status: COMPLETED | Results posted: 2017-04-10